RADX Radiopharm Theranostics Limited
$1.98▼ -3.88%
Healthcare
Other
After hours
$1.98▲ +0.00%
Sep 11, 4:10 PM ET
Volume 37.0K
Avg Volume (10D) 66.5K
Key Metrics & Fundamentals
Market Cap
$28.63M
P/E Ratio
–
Div Yield
–%
52W Range
1.98 - 16.25
% vs 50 MA
-35.11%
% vs 200 MA
-52.64%
RSI-14
26.7
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.59
Free Cash Flow
-$8.74M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
GlobeNewswire · Sep 9, 2026 11:00 AM
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
GlobeNewswire · Aug 26, 2026 11:00 AM
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
GlobeNewswire · Aug 20, 2026 11:00 AM
Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
GlobeNewswire · Aug 17, 2026 11:30 AM
RADX: RAD101 Topline & FY:26 Cash Flows
Zacks Small Cap Research · Aug 3, 2026 3:14 PM
Radiopharm Theranostics Reports Business Update
GlobeNewswire · Jul 31, 2026 11:00 AM
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
GlobeNewswire · Jul 24, 2026 11:15 AM
Radiopharm Says Third Dosing Group of Phase 1 RAD204 Trial Achieves Partial Response
MT Newswires · Jul 22, 2026 11:40 AM
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
GlobeNewswire · Jul 22, 2026 11:05 AM
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
GlobeNewswire · Jul 22, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RADX's money flow as a full page
Social Sentiment
No Reddit posts found for RADX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.